155 related articles for article (PubMed ID: 32736772)
1. An overview of thrombotic complications of old and new anticancer drugs.
Levi M; Sivapalaratnam S
Thromb Res; 2020 Jul; 191 Suppl 1():S17-S21. PubMed ID: 32736772
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathies and antineoplastic agents.
Grangé S; Coppo P;
Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.
Levi M
Hemasphere; 2021 Jun; 5(6):e571. PubMed ID: 34095755
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in stem cell transplantation.
Kansu E
Hematology; 2012 Apr; 17 Suppl 1():S159-62. PubMed ID: 22507809
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy, cancer, and cancer drugs.
Izzedine H; Perazella MA
Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
[TBL] [Abstract][Full Text] [Related]
7. Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma.
Hamad CD; Hoelscher ZC; Tchakarov A; Kala J
CEN Case Rep; 2022 Aug; 11(3):321-327. PubMed ID: 34997535
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Risk from Chemotherapy and Other Cancer Therapies.
Debbie Jiang MD; Alfred Ian Lee MD
Cancer Treat Res; 2019; 179():87-101. PubMed ID: 31317482
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
11. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy.
Mathew RO; Nayer A; Asif A
J Am Soc Hypertens; 2016 Apr; 10(4):352-9. PubMed ID: 26778772
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy syndromes.
Zakarija A
Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
[No Abstract] [Full Text] [Related]
13. Sunitinib-induced thrombotic microangiopathy.
Noronha V; Punatar S; Joshi A; Desphande RV; Prabhash K
J Cancer Res Ther; 2016; 12(1):6-11. PubMed ID: 27072203
[TBL] [Abstract][Full Text] [Related]
14. An overview of hematopoietic stem cell transplantation related thrombotic complications.
Sahin U; Ataca Atilla P; Atilla E; Toprak SK; Demirer T
Crit Rev Oncol Hematol; 2016 Nov; 107():149-155. PubMed ID: 27823643
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
[TBL] [Abstract][Full Text] [Related]
16. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
[TBL] [Abstract][Full Text] [Related]
17. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
Eremina V; Quaggin SE
Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
[TBL] [Abstract][Full Text] [Related]
18. Drug-related thrombosis in hematologic malignancies.
Nadir Y; Hoffman R; Brenner B
Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
[TBL] [Abstract][Full Text] [Related]
19. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
[TBL] [Abstract][Full Text] [Related]
20. [Management of transplant-associated thrombotic microangiopathy].
Ikezoe T
Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
